COMP <GO>

OKUR vs HURA // 10Y YIELD & FRED MACRO BETA

OnKure Therapeutics Inc. (Class A) (NASDAQ) VS. TuHURA Biosciences Inc. (NASDAQ) • 15-METRIC TALLY: OKUR 2 — HURA 1

■ METRIC PARITY

LAST: $2.50 (-3.47%) • MKT CAP: $104.9M

macro-sensitivity

—

LAST: $1.66 (-3.78%) • MKT CAP: $109.6M

macro-sensitivity

—

15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (OKUR VS. HURA) EMERALD CELL = QUANTITATIVE EDGE

INSTITUTIONAL METRIC	OKUR	HURA	SPREAD (A - B)	ADVANTAGE	DEDICATED URL
Gross Profit Margin	—	—	—	TIE	/gross-margins <GO>
Return on Invested Capital (ROIC)	-35.00%	-35.00%	0.00	TIE	/roic <GO>
EV/EBITDA & P/E Valuation	—	—	—	TIE	/valuation <GO>
Free Cash Flow Yield	—	-21.10%	—	TIE	/fcf-yield <GO>
Operating Margin	—	—	—	TIE	/operating-margins <GO>
Net Profit Margin	—	—	—	TIE	/net-margins <GO>
Revenue Growth (YoY)	—	—	—	TIE	/revenue-growth <GO>
Dividend Yield & FCF Payout Safety	0.00%	0.00%	0.00	TIE	/dividend-safety <GO>
Altman Z-Score & Debt/Equity	—	—	—	TIE	/balance-sheet <GO>
Piotroski F-Score Quality	2/9	1/9	+1.00	OKUR	/piotroski-score <GO>
Options Implied Move & Put/Call Skew	—	—	—	TIE	/options-implied-move <GO>
RSI-14 & 200D SMA Momentum	49.3	39.5	+9.80	OKUR	/rsi-technicals <GO>
10Y Yield & FRED Macro Beta ACTIVE	—	—	—	TIE	/macro-sensitivity <GO>
Forward P/E Multiple	—	—	—	TIE	/forward-pe <GO>
Enterprise Scale & Market Cap	$104.9M	$109.6M	-$4.7M	HURA	/market-cap <GO>

5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY

FISCAL YEAR	OKUR REV	HURA REV	OKUR GROSS %	HURA GROSS %	OKUR FCF	HURA FCF
FY 2025	$176.3M	$11.5M	—	—	-$51.9M	-$27.7M
FY 2024	$152.3M	$8.4M	—	—	-$51.2M	-$14.8M
FY 2023	$103.4M	$67.5M	—	—	-$34.5M	-$12.0M

FRED MACRO REGIME CORRELATION COMPARISON PEARSON r

OKUR // BETA —

HURA // BETA —